What atomoxetine is, in plain English
Atomoxetine is a prescription capsule used to treat attention-deficit/hyperactivity disorder (ADHD). It is a selective norepinephrine reuptake inhibitor: a non-stimulant that changes how the brain handles one signaling chemical. US labeling covers ADHD in adults and in children aged 6 and older. It is sold as a generic and under the brand name Strattera.
Most people arrive at this page for one of three reasons. They have been offered a non-stimulant and want to know what taking it is actually like. They are weighing it against a stimulant. Or they want to know what one month costs when they pay for it themselves. This guide covers all three, plus the warnings the label treats as serious.
One framing point first. This is a prescription-only medicine that carries a boxed warning, the strongest warning the FDA puts on a label. That does not make it dangerous for everyone. It does mean the risks below deserve a real conversation with a prescriber rather than a quick skim. If you are comparing several treatments at once, the Medication Index holds plain-English pages on other drugs in the same conversation.
How the medicine works, and why it is slow
Norepinephrine is a chemical messenger. Nerve cells release it, then pull most of it back in through a transporter protein. This drug blocks that transporter. More norepinephrine stays available in the gap between cells, especially in the prefrontal cortex, the brain region tied to planning, working memory and impulse control. Published reviews of the drug describe this as its main action, and a clinical review of atomoxetine in child and adult ADHD sets out that mechanism in detail: a peer-reviewed overview of the drug’s pharmacology.
Because it is not a stimulant, it does not drive dopamine in reward pathways the way amphetamine and methylphenidate products do. That is one reason it is not a federally controlled substance. In practice that changes the paperwork: refills follow ordinary prescription rules rather than the tighter rules attached to controlled stimulants.
The bigger practical difference is timing. A stimulant acts within hours, so you can judge a dose the same day. This medicine builds. Clinical trials measured its effect over weeks, and prescribers usually ask patients to stay at a steady dose for several weeks before deciding whether it helps. Patient-facing guidance from a major US medical center describes the same slow build: an overview written for patients and caregivers.
There is also no on and off pattern through the day. Taken consistently, it works around the clock, which some people prefer for evenings, weekends and homework hours. Missing one day does not cause withdrawal, but frequent skipped doses undercut the whole point of a medicine that works by accumulating.
What the FDA label approves it for
The approved use is ADHD, full stop. The label states that efficacy was established in seven outpatient trials: four short trials lasting 6 to 9 weeks in patients aged 6 to 18, two 10-week trials in adults, and one maintenance trial in children aged 6 to 15. Use is approved from age 6 upward. Safety and effectiveness in younger children have not been established.
A common search question is whether this is an antidepressant. It belongs to the same broad mechanism family as some antidepressants that act on norepinephrine, and it was studied as a depression treatment before it was developed for ADHD. It is not approved to treat depression, and it is not approved to treat anxiety. Clinicians sometimes prescribe medicines off-label, meaning outside the approved indication, and some consider this one when ADHD sits alongside anxiety. The evidence there is thinner, and the boxed warning about suicidal thinking in young people applies no matter why the drug is prescribed.
Does it help ADHD symptoms? In trials, average symptom scores improved compared with placebo. A published review noted that it is often considered for people at risk of substance misuse, and for those with co-occurring anxiety or tics, or who prefer not to take a stimulant: a review of its use in ADHD. Averages are not promises. Response varies widely between individuals, and some people get little benefit and stop.
Forms, brand names and how it is taken
The product is an oral capsule. The brand name is Strattera. Generic atomoxetine hydrochloride capsules are made by several manufacturers and repackagers, which is why the pill you receive may look different from one refill to the next.
Capsules are swallowed whole. The label warns against opening them, because the powder inside can irritate the eyes. If the contents do reach an eye, rinse with water and get medical advice promptly.
The medicine is taken once daily, usually in the morning, or split into a morning dose and a late afternoon or early evening dose. It can be taken with or without food, and taking it with food may ease nausea for some people.
On dosing, follow the label and your prescriber rather than anything you read online. In broad terms, the label describes adult dosing as fixed amounts and dosing in children and adolescents as based on body weight, with a starting amount that is increased after a minimum number of days, and an upper daily limit. People who process the drug slowly because of the liver enzyme CYP2D6, or who take a strong inhibitor of that enzyme, may be moved up more gradually. Do not adjust your own dose, and do not double up after a missed one without asking.
Stopping is simpler than many people expect: the label states the drug may be discontinued without tapering. Even so, talk with your prescriber first, because stopping usually means deciding what comes next.
Side effects people report most often
Most reported effects cluster around the stomach, appetite, sleep, blood pressure and, in adults, the bladder and sexual function. Many are strongest in the first weeks and settle. A national consumer drug reference lists the common and serious effects in full: the MedlinePlus entry for this medicine.
In children and teenagers, commonly reported effects include stomach upset, reduced appetite, nausea, vomiting, tiredness, dizziness, irritability and mood swings.
In adults, common reports include dry mouth, trouble sleeping, nausea, constipation, reduced appetite, dizziness, sweating and fatigue. Adults also report urinary hesitancy or difficulty emptying the bladder, plus sexual effects such as lower libido, erection problems and trouble with ejaculation. Menstrual changes have been reported too. These are worth raising rather than tolerating in silence, because they are known effects and not something you imagined.
Small average increases in heart rate and blood pressure are expected, which is why readings are usually taken before starting and rechecked after dose changes.
On the weight question: appetite loss and modest early weight loss are far more typical than weight gain, and weight often recovers as treatment continues. In children, height and weight are tracked over time because growth can slow. This is not a weight loss treatment and should never be used as one.
Over the longer term, the drug is not habit forming and has no recognized misuse potential. Long-term monitoring tends to focus on growth in children, blood pressure and pulse, mood and behavior, and any hint of liver trouble.
The boxed warning and other serious risks
The boxed warning is specific: the drug increased the risk of suicidal ideation in short-term studies in children and adolescents with ADHD. Anyone considering it for a young person must weigh that risk against the clinical need, and other conditions that often accompany ADHD can raise that risk on their own. Patients starting treatment should be watched closely for suicidal thinking or behavior, worsening symptoms, and unusual behavior changes, particularly in the first months and after any dose change. This wording comes from the official prescribing information: the current US label on DailyMed. Families should call the prescriber about new agitation, panic, aggression, sleeplessness or withdrawal. In the US, the 988 Suicide and Crisis Lifeline is reachable by call or text at any hour.
Severe liver injury is rare but is treated seriously. The label says treatment should be stopped and not restarted in patients with jaundice or laboratory evidence of liver injury. Warning signs include yellowing of the skin or eyes, dark urine, itching, pain in the upper right side of the belly, and unexplained flu-like tiredness. Those symptoms need prompt medical attention.
Serious cardiovascular events, including sudden death, stroke and heart attack, have been reported in association with treatment. The label calls for a careful history and physical examination to look for heart disease before starting, and states the drug generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy or serious heart rhythm problems, or in adults with serious cardiovascular disease. A family history of sudden cardiac death is worth mentioning at the first visit.
Other precautions in the label include new psychotic or manic symptoms, so screening for bipolar disorder matters before starting; reports of aggression and hostility; allergic reactions such as rash, hives and swelling of the face or throat; urinary retention and hesitancy in adults; and priapism, a painful erection lasting several hours, which is a medical emergency. Growth is monitored in children for the same reason appetite is.
Interactions and who should not take it
Some combinations are ruled out rather than managed. According to the prescribing information, the medicine should not be used with a monoamine oxidase inhibitor (MAOI), or within 14 days of stopping one, because serious and sometimes fatal reactions have occurred. It is also contraindicated in narrow-angle glaucoma, in people with pheochromocytoma or a history of it, in severe cardiovascular disorders likely to worsen with meaningful increases in blood pressure or heart rate, and in anyone with a known hypersensitivity to it.
Beyond those, the interactions that come up most often are:
- Strong CYP2D6 inhibitors, including paroxetine, fluoxetine and quinidine, which can raise drug levels substantially and may call for slower dose increases.
- Genetic poor metabolizers of CYP2D6, who clear the drug more slowly and may feel side effects sooner.
- Beta-2 agonists such as albuterol, and other blood pressure raising agents, which can add to effects on heart rate and blood pressure.
- Any other medicine that raises blood pressure or pulse, including over-the-counter decongestants and herbal stimulants.
Give your prescriber the full list: other ADHD medicines, antidepressants, heart and blood pressure drugs, supplements and anything taken occasionally. Also mention liver problems, seizures, urinary problems, pregnancy or plans to become pregnant, and breastfeeding, since data in pregnancy are limited and the decision is individual.
Non-stimulant or stimulant: how the choice is usually made
This is the comparison behind most searches, and it is less about which drug is stronger than about which trade-offs a person can live with.
| What differs | Atomoxetine | Stimulants (amphetamine or methylphenidate based) |
|---|---|---|
| Drug class | Selective norepinephrine reuptake inhibitor, a non-stimulant | Central nervous system stimulants |
| Controlled substance status | Not federally scheduled | Schedule II controlled substances |
| How soon an effect is judged | Weeks at a steady dose | Often within hours of a dose |
| Pattern through the day | Daily dosing with no clear on and off cycle | Effect tracks the dose and then wears off |
| Commonly discussed downsides | Stomach upset, appetite loss, sleep changes, blood pressure rise, boxed warning on suicidal thinking in young people | Appetite loss, sleep problems, blood pressure and heart rate rise, misuse and diversion risk |
| Refill logistics | Ordinary prescription rules | Tighter refill and remote prescribing rules |
US public health guidance generally treats stimulants as the usual first medication choice for people aged 6 and older, with non-stimulants as alternatives when a stimulant is not tolerated, not effective, not appropriate or not wanted: federal guidance on ADHD treatment options. Behavioral therapy sits alongside medication in that guidance, not underneath it.
Atomoxetine vs. Stimulants: Key Differences
| Atomoxetine | Stimulants | |
|---|---|---|
| Controlled substance | Not scheduled | Schedule II |
| Time to judge effect | Weeks at steady dose | Often within hours |
| Daily pattern | No on/off cycle | Wears off between doses |
| Refill rules | Ordinary prescription | Tighter restrictions |
The non-stimulant shelf is not one product. Extended release guanfacine and clonidine are also used, and viloxazine is another non-stimulant option. If you are working through that shelf, our pages on Guanfacine For ADHD and Methylphenidate Explained cover how those differ in practice.
What a month costs when you pay cash
Two payment routes matter here and they should never be blended. Cash pay is what a self-pay patient hands over each month. The insurance route is the plan or membership fee only, and it excludes copays and deductibles, which vary by plan and by state.
Across the self-pay telehealth programs tracked here that can prescribe this medicine, the lowest recurring monthly price is and the median sits at . Advertised prices move, so treat any figure as a snapshot rather than a fixed rate.
What actually moves your monthly number:
- Generic versus brand. Generic capsules are widely available, and brand pricing is a different conversation entirely.
- Pharmacy. Cash prices for the same generic differ between pharmacies, and mail fulfillment differs from a local counter.
- Dose strength and how many capsules a day you take.
- Whether a telehealth membership bundles the visit, messaging and dose adjustments, or bills each visit separately.
- Whether the medication itself is included in the monthly fee or paid at the pharmacy on top of it.
- Introductory pricing versus the renewal price after the first billing cycle.
Monthly figures are easy to underestimate over a year of treatment, so it helps to see the twelve month total before committing.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
On coverage, be careful with assumptions. Some plans cover generic versions of this medicine at a low tier, others apply step therapy, which means trying a preferred option first, or require prior authorization. A telehealth program may or may not be able to bill your plan at all. The only reliable answer comes from your own formulary and member services, checked against the specific product and strength. Comparing the two routes side by side is usually the fastest way to see which one is cheaper for you.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
If you would rather see how a cost comparison is laid out before doing your own, the Free Savings Report shows the format, and the Free Health Calculators cover the arithmetic side of ongoing treatment.
How telehealth programs handle this prescription
Because this drug is not a controlled substance, remote prescribing is less restricted than it is for stimulants. That does not make every program the same. State rules still govern telemedicine prescribing, and some states expect a live video visit before a first prescription, so availability differs by where you live.
The things that genuinely vary between programs:
- Which states they are licensed in, and whether they treat children and teenagers or adults only.
- Whether they require prior records, rating scales or a formal diagnostic assessment before prescribing.
- Whether they will continue a prescription started elsewhere, or insist on their own evaluation first.
- Whether they prescribe stimulants at all, which matters if the non-stimulant does not suit you.
- Follow-up cadence, and whether check-ins during dose changes cost extra.
- Whether blood pressure and pulse checks are built into the process, and how they are collected remotely.
- Pharmacy choice: sent to your local pharmacy, or filled through a mail partner.
- What happens if you stop treatment mid-cycle, including refund and cancellation terms.
RatedByPatients is an independent comparison and community review site. It does not prescribe, dispense or sell anything, so the pages here are patient review and comparison pages rather than endorsements. You can browse programs in the Telehealth Provider Directory, and the scoring dimensions behind those pages are set out in How Provider Scores Work.
Questions worth asking before the first prescription
Bring these to the visit. They cover screening, monitoring and the exit plan, which is the part people forget to ask about.
Questions to Ask Before Your First Prescription
- Why this non-stimulant rather than a stimulant or another option?
- What heart, blood pressure and family history do you need before I start?
- How long should I stay at a steady dose before judging whether it works?
- Which side effects need immediate reporting vs. those that usually settle?
- What are the warning signs of liver trouble?
- Which of my other medicines or supplements interact with this one?
- What is the plan if this does not help?
- Given my history, why this non-stimulant rather than a stimulant or another option?
- What heart, blood pressure and family history questions do you need answered before I start?
- How long should I stay at a steady dose before we judge whether it is working?
- What will you measure to decide it is working, and how will we track it?
- Which side effects should I report right away, and which usually settle on their own?
- What are the warning signs of liver trouble, and what should I do if I notice them?
- For a child or teenager: what should we watch for in mood and behavior, and how often will you check in?
- Which of my other medicines and supplements interact with this one?
- How will growth, weight, blood pressure and pulse be monitored over time?
- What is the plan if this does not help, and what would we try next?
Signs that need urgent attention
Most side effects are mild and manageable. A few are not. Get emergency care for chest pain, fainting, signs of a stroke such as sudden weakness, slurred speech or facial drooping, swelling of the face, lips or throat, trouble breathing, or an erection lasting more than four hours. Contact a clinician promptly for yellowing skin or eyes, dark urine, persistent upper right belly pain, or unexplained tiredness with flu-like symptoms.
For new or worsening thoughts of self-harm, sudden agitation, or a sharp change in behavior, especially in a child or teenager, contact the prescriber the same day. In the US, the 988 Suicide and Crisis Lifeline is available by call or text around the clock
